These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34665703)

  • 21. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
    Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
    Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
    Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
    Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
    Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
    Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
    Anquetil C; Hachulla E; Machuron F; Mariette X; Le Guern V; Vittecoq O; Dernis E; Larroche C; Dubost JJ; Perdriger A; Devauchelle-Pensec V; Fauchais AL; Morel J; Dieudé P; Rist S; Sene D; Gottenberg JE; Hatron PY
    Rheumatology (Oxford); 2019 Jul; 58(7):1163-1167. PubMed ID: 30561748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
    Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK
    J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sjogren's syndrome in Israel: primary versus secondary disease.
    Tishler M; Aharon A; Ehrenfeld M; Avni I; Bendet E; Bombardieri S; Yaron M; Shoenfeld Y
    Clin Rheumatol; 1994 Sep; 13(3):438-41. PubMed ID: 7835006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
    Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
    Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult primary Sjögren Syndrome in patients with interstitial pneumonia with autoimmune features.
    Auteri S; Alberti ML; Fernández ME; Blanco G; Rayá M; Guman G; Garbarino MC; Carballo OG; Caro F
    Respir Med; 2021 Jun; 182():106405. PubMed ID: 33894442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye.
    Liew MS; Zhang M; Kim E; Akpek EK
    Br J Ophthalmol; 2012 Dec; 96(12):1498-503. PubMed ID: 23001257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.
    Ramos-Casals M; Acar-Denizli N; Vissink A; Brito-Zerón P; Li X; Carubbi F; Priori R; Toplak N; Baldini C; Faugier-Fuentes E; Kruize AA; Mandl T; Tomiita M; Gandolfo S; Hashimoto K; Hernandez-Molina G; Hofauer B; Mendieta-Zerón S; Rasmussen A; Sandhya P; Sene D; Trevisani VFM; Isenberg D; Sundberg E; Pasoto SG; Sebastian A; Suzuki Y; Retamozo S; Xu B; Giacomelli R; Gattamelata A; Bizjak M; Bombardieri S; Loor-Chavez RE; Hinrichs A; Olsson P; Bootsma H; Lieberman SM;
    Rheumatology (Oxford); 2021 Oct; 60(10):4558-4567. PubMed ID: 33493333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
    Retamozo S; Acar-Denizli N; Rasmussen A; Horváth IF; Baldini C; Priori R; Sandhya P; Hernandez-Molina G; Armagan B; Praprotnik S; Kvarnstrom M; Gerli R; Sebastian A; Solans R; Rischmueller M; Pasoto SG; Valim V; Nordmark G; Kruize A; Nakamura H; Hofauer B; Giacomelli R; Fernandes Moça Trevisani V; Devauchelle-Pensec V; Atzeni F; Gheita TA; Consani-Fernández S; Szántó A; Sivils K; Gattamelata A; Danda D; Kilic L; Bartoloni E; Bombardieri S; Sánchez-Guerrero J; Wahren-Herlenius M; Mariette X; Ramos-Casals M; Brito-Zerón P;
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):97-106. PubMed ID: 31464664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2016 classification criteria for primary Sjogren's syndrome: what's new?
    Franceschini F; Cavazzana I; Andreoli L; Tincani A
    BMC Med; 2017 Mar; 15(1):69. PubMed ID: 28359271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aseptic meningitis as initial presentation of subclinical Sjögren's syndrome: Could the cerebrospinal fluid anti-Ro/SSA and anti-La/SSB antibody system be the culprit?
    Kurotaki K; Fujita M; Aizawa T; Tsugawa K; Tanaka H
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):217-219. PubMed ID: 35134231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.